NewsPanacea Biotec Receives Rectified Assessment Order, Tax Liability Reduced to Nil for AY 2015-16Panacea Biotec Receives Rectified Assessment Order, Tax Liability Reduced to Nil for AY 2015-16
Panacea Biotec Limited has received a favorable rectified Assessment Order from the Income Tax Department that has reduced its tax liability to nil for Assessment Year 2015-16. The rectification addressed errors in the original February 27, 2026 assessment that had created a ₹45.71 crore tax demand, including double addition of disallowances and omission of brought-forward loss set-offs. The company successfully filed a rectification application under the Income Tax Act, 1961, resulting in the DCIT issuing a corrected order on April 06, 2026, with positive financial implications and no adverse operational impact.
*this image is generated using AI for illustrative purposes only.
Panacea Biotec Limited has successfully obtained a rectified Assessment Order from the Income Tax Department that has nullified its tax liability for Assessment Year 2015-16. The company disclosed this development to stock exchanges on April 07, 2026, under Regulation 30 of SEBI LODR Regulations.
Background of Tax Assessment Issue
The Deputy Commissioner of Income Tax (DCIT), New Delhi, had initially issued a demand order dated February 27, 2026, disallowing certain expenditure and creating a total tax demand of ₹45.71 crore for Assessment Year 2015-16. This original assessment contained several errors that prompted the company to seek rectification.
Rectification Application and Resolution
Panacea Biotec subsequently filed a rectification application under the Income Tax Act, 1961, to correct errors that were apparent from the record. The key issues addressed in the rectification application included:
- Double addition of disallowances
- Omission of set-off for brought-forward losses
Rectified Assessment Order Details
The DCIT issued the rectified Assessment Order on April 06, 2026, which the company received the same day. The rectified order addressed all the identified errors and determined the company's tax liability for Assessment Year 2015-16 as nil.
| Parameter: | Details |
|---|---|
| Original Demand: | ₹45.71 crore |
| Rectified Liability: | Nil |
| Assessment Year: | 2015-16 |
| Authority: | Deputy Commissioner of Income Tax, New Delhi |
| Rectification Date: | April 06, 2026 |
Financial Impact and Company Position
The rectification has resulted in a positive financial impact for Panacea Biotec, as it has successfully nullified the entire tax demand for the assessment year in question. The company has stated that it does not foresee any adverse impact on its financial, operational, or other activities arising from this rectified order.
The successful resolution of this tax matter eliminates a potential financial liability and provides clarity on the company's tax position for Assessment Year 2015-16. No penalties, restrictions, or sanctions have been imposed pursuant to the rectified communication, and no further actions are required from the company regarding this matter.
Historical Stock Returns for Panacea Biotec
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.44% | +0.71% | +2.23% | -24.02% | -26.18% | +39.88% |
Will this successful tax rectification improve Panacea Biotec's cash flow position and enable increased R&D investments in its biotechnology pipeline?
Could this favorable tax resolution signal potential similar outcomes for other pending assessment years that the company might be facing?
How might this ₹45.71 crore liability elimination impact Panacea Biotec's credit rating and borrowing capacity for future expansion plans?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
